Biotech R&D and manufacturing for molecular biology reagents and kits
Meilune is a research-stage biotech company in China operating a mix of molecular biology research, process development, and kit manufacturing. The tech stack—GraphPad Prism, SnapGene, CRISPR-Cas9, LC-MS, HPLC, GC-MS, SciFinder—reflects active bench work in gene editing, analytical chemistry, and assay optimization. Hiring is heavily weighted toward sales (14 roles) relative to engineering (2), suggesting a commercial-stage push for existing products rather than platform-building.
Meilune develops and manufactures molecular biology reagents, kits, and custom expression cell lines for research and diagnostic applications. The company is based in Dalian, China, and operates across three interconnected areas: process development (purification, scale-up, route selection), product optimization (kit performance tuning, quality certification), and cell line engineering (stable expression systems, vector construction, CRISPR optimization). Current projects span reagent innovation, cell line establishment, and production planning, with active scaling challenges around cost control and process robustness as products move from milligram to kilogram quantities.
Meilune uses SnapGene and GraphPad Prism for design and analysis, CRISPR-Cas9 for gene editing, LC-MS and HPLC for analytical characterization, GC-MS for purity assessment, and SciFinder for literature research. GCP is listed as a cloud platform.
Yes. Meilune has 14 active sales roles open (as of latest data). There are 29 total active roles across the company, primarily in sales, research, and support functions.
Current projects include innovative reagent development, stable expression cell line establishment, CRISPR vector construction and optimization, purification process development, and scale-up optimization from laboratory to production scale.
Other companies in the same industry, closest in size